One-carbon Therapeutics AB is a clinical-stage company headquartered in Sweden
At One-carbon Therapeutics we are committed to pioneering first-in-class anti-cancer therapies that push the treatment boundaries in the field of oncology. Working alongside leading researchers, clinicians and technology innovators, we are shaping a new era of patient-focused cancer care.
Our team has extensive experience in oncology, drug discovery, and development. We are inspired by science and committed to delivering better precision medicines to patients.
Solna, Sweden, December 1, 2025. One-carbon Therapeutics AB, a clinical-stage biotechnology company pioneering first-in-class cancer therapies, announced today the closing of an oversubscribed 153 million
Stockholm, Sweden. November 17th, 2025. One-carbon Therapeutics AB, a clinical-stage biotechnology company pioneering a novel cancer therapy, today announced that the first subject has been successfully dosed